BioSpace2h
Regenxbio Gears Up to Challenge Sarepta in DMD as Gene Therapy Advances to Pivotal Studies
Regenxbio is pushing its Duchenne muscular dystrophy gene therapy into pivotal development, with a BLA planned for ...
GMA Network10h
Vaccine shows early promise against aggressive breast cancer
A small trial of an experimental vaccine has shown promising results for patients with the most aggressive type of breast ...
Reuters15h
Health Rounds: Vaccine shows early promise against aggressive breast cancer
Specifically, StitchR restored the protein Dystrophin, which is absent in patients with Duchenne muscular dystrophy, and the ...
FierceBiotech20h
After seeing improved muscle function in phase 1/2 trial, Regenxbio launches pivotal DMD study
Regenxbio’s investigational gene therapy improved muscle function for patients with Duchenne muscular dystrophy (DMD) in a phase 1/2 study. | Regenxbio’s investigational gene therapy improved muscle ...
ENDPOINTS NEWS22h
Re­genxbio shares first da­ta show­ing Duchenne gene ther­a­py im­proves mus­cle func­tion
Regenxbio reported improved muscle function in boys with Duchenne muscular dystrophy using their gene therapy RGX-202. The ...